2m 2m 2m 2m 2m 2m 2m
ESTABL (ESTA)
NASDAQ
$71.31-$1.10 (-1.52%)
Price as of Jun 03, 2026 5:35 PM EDT- $959.7MMarket Cap
- 91.85%1-Year Change
- Medical DevicesIndustry
ESTABL (ESTA)
$71.31-$1.10 (-1.52%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 211.1M +27.14% | 166.0M +0.53% | 165.2M +2.13% | 161.7M +27.64% | |
Cost of Revenue | 64.8M +14.63% | 56.5M -2.88% | 58.2M +5.57% | 55.1M +33.50% | |
Gross Profit | 146.3M +33.58% | 109.5M +2.38% | 107.0M +0.36% | 106.6M +24.81% | |
Sales and Marketing Expense | 165.1M +18.07% | 139.8M -3.96% | 145.6M +15.55% | 126.0M +36.60% | |
Research and Development Expense | -20.2M +2.75% | -19.7M -25.44% | -26.4M +30.39% | -20.3M +10.67% | |
Depreciation and Amortization Expense | 3.3M +57.14% | 2.1M +75.00% | 1.2M 0.00% | 1.2M 0.00% | |
Total Operating Expenses | 185.3M +16.18% | 159.5M -7.26% | 172.0M +17.61% | 146.3M +32.30% | |
Operating Profit | -39.0M -21.96% | -50.0M -23.13% | -65.0M +63.97% | -39.7M +57.75% | |
Interest Income | 423,000 -71.36% | 1.5M +44.80% | 1.0M +1,072.41% | 87,000 +278.26% | |
Interest Expense | -24.5M +16.11% | -21.1M +37.08% | -15.4M +30.89% | -11.8M +29.77% | |
Interest Income and Expense and Net | -24.1M +22.70% | -19.6M +36.53% | -14.4M +23.13% | -11.7M +29.14% | |
Total Nonoperating Income and Expense | 5.8M +138.06% | -15.3M -1,973.65% | 816,000 +125.68% | -3.2M -49.33% | |
Income before Taxes | -58.0M -31.44% | -84.6M +7.69% | -78.6M +7.91% | -72.8M +83.38% | |
Income Taxes | -7.0M +21,643.75% | -32,000 -60.49% | -81,000 -103.40% | 2.4M +67.13% | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Net Income | -51.1M -39.64% | -84.6M +7.76% | -78.5M +4.38% | -75.2M +82.82% | |
Net Income from Continuing Operations Applicable to Common | -58.0M -31.44% | -84.6M +7.69% | -78.6M +7.91% | -72.8M +83.38% | |
Basic EPS and Net Income | -1.72 -42.67% | -3.00 -2.28% | -3.07 -0.32% | -3.08 +79.07% | |
Diluted EPS and Net Income | -1.72 -42.67% | -3.00 -2.28% | -3.07 -0.32% | -3.08 +79.07% | |
Basic Weighted Average Shares | 29.6M +5.18% | 28.2M +10.01% | 25.6M +4.67% | 24.5M +2.02% | |
Diluted Weighted Average Shares | 29.6M +5.18% | 28.2M +10.01% | 25.6M +4.67% | 24.5M +2.02% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 75.6M -16.35% | 90.3M +125.67% | 40.0M -39.67% | 66.4M +24.23% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 75.6M -16.35% | 90.3M +125.67% | 40.0M -39.67% | 66.4M +24.23% | |
Total Current Assets | 249.9M +2.84% | 243.0M +38.96% | 174.9M +16.68% | 149.9M +32.34% | |
Accumulated Depreciation | 26.2M +30.31% | 20.1M +23.21% | 16.3M +19.87% | 13.6M +14.56% | |
Property and Plant and Equipment and Net | 75.6M -3.09% | 78.0M +1.07% | 77.2M +51.11% | 51.1M +173.83% | |
Total Long-Term Assets | 16.1M +120.46% | 7.3M +55.53% | 4.7M +264.50% | 1.3M +131.18% | |
Total Assets | 357.2M +2.98% | 346.8M +29.11% | 268.6M +27.28% | 211.1M +51.27% | |
Income Taxes Payable | 377,000 +146.41% | 153,000 +40.37% | 109,000 N/A | N/A N/A | |
Total Short-Term Debt | 10.0M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 82.1M +20.31% | 68.3M +19.47% | 57.1M +46.69% | 39.0M +22.17% | |
Total Long-Term Debt | 247.5M +12.73% | 219.6M +16.34% | 188.7M N/A | 0 -100.00% | |
Total Long-Term Liabilities | 1.1M -32.30% | 1.7M +2.01% | 1.6M +1.17% | 1.6M -32.02% | |
Total Liabilities | 333.6M +13.58% | 293.7M +17.38% | 250.2M +14.14% | 219.2M +146.93% | |
Retained Earnings | -495.8M +11.48% | -444.7M +23.49% | -360.1M +27.88% | -281.6M +36.44% | |
Total Stockholders Equity | 23.5M -55.65% | 53.1M +188.64% | 18.4M +324.74% | -8.2M -116.13% | |
Total Shares Outstanding | 29.3M +1.80% | 28.8M +10.35% | 26.1M +6.88% | 24.4M +1.36% | |
Cash Flow | |||||
Cash from Operating Activities | -50.9M -13.03% | -58.5M -33.89% | -88.5M +69.68% | -52.2M +89.47% | |
Capital Expenditures | 6.0M -1.06% | 6.1M -22.69% | 7.9M +177.38% | 2.9M +17.57% | |
Cash from Investing Activities | -7.0M -54.98% | -15.6M -36.40% | -24.5M -29.44% | -34.8M +385.70% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 40.4M -67.88% | 125.9M +46.00% | 86.2M -13.99% | 100.3M +2,374.21% | |
Financials Ratio | |||||
Gross Margin | 69.32% +5.07% | 65.97% +1.84% | 64.78% -1.74% | 65.92% -2.22% | |
Operating Margin | -18.48% -38.62% | -30.11% -23.53% | -39.37% +60.54% | -24.53% +23.59% | |
Return on Assets | -14.51% -47.23% | -27.49% -16.01% | -32.73% -23.71% | -42.90% +54.31% | |
Return on Equity | -133.25% -43.70% | -236.67% -84.61% | -1,537.75% +335.04% | -353.48% +440.02% | |
Revenue Growth | 27.14% +5,027.57% | 0.53% -75.20% | 2.13% -92.28% | 27.64% -44.28% | |
Current Ratio | 3.04 -14.52% | 3.56 +16.31% | 3.06 -20.46% | 3.85 +8.32% | |
Cash Ratio | 0.92 -30.47% | 1.32 +88.89% | 0.70 -58.87% | 1.70 +1.68% | |
Debt-to-Equity Ratio | 10.94 N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.72 N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow